Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Diagnostic and prognostic utility of PD-1 in B cell lymphomas.

Muenst S, Hoeller S, Willi N, Dirnhofera S, Tzankov A.

Dis Markers. 2010;29(1):47-53. doi: 10.3233/DMA-2010-0725.

2.

Increased programmed death-1+ tumor-infiltrating lymphocytes in classical Hodgkin lymphoma substantiate reduced overall survival.

Muenst S, Hoeller S, Dirnhofer S, Tzankov A.

Hum Pathol. 2009 Dec;40(12):1715-22. doi: 10.1016/j.humpath.2009.03.025. Epub 2009 Aug 19.

PMID:
19695683
3.

Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia.

Xerri L, Chetaille B, Serriari N, Attias C, Guillaume Y, Arnoulet C, Olive D.

Hum Pathol. 2008 Jul;39(7):1050-8. doi: 10.1016/j.humpath.2007.11.012. Epub 2008 May 13. Erratum in: Hum Pathol. 2010 Nov;41(11):1655. Seriari, Nacer [corrected to Serriari, Nacer].

PMID:
18479731
4.

Follicular programmed death 1-positive lymphocytes in the tumor microenvironment are an independent prognostic factor in follicular lymphoma.

Richendollar BG, Pohlman B, Elson P, Hsi ED.

Hum Pathol. 2011 Apr;42(4):552-7. doi: 10.1016/j.humpath.2010.08.015. Epub 2011 Jan 15.

PMID:
21237493
5.

Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma.

Dorfman DM, Brown JA, Shahsafaei A, Freeman GJ.

Am J Surg Pathol. 2006 Jul;30(7):802-10.

6.

High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma.

Carreras J, Lopez-Guillermo A, Roncador G, Villamor N, Colomo L, Martinez A, Hamoudi R, Howat WJ, Montserrat E, Campo E.

J Clin Oncol. 2009 Mar 20;27(9):1470-6. doi: 10.1200/JCO.2008.18.0513. Epub 2009 Feb 17.

7.

Programmed death-1 expression in cutaneous B-cell lymphoma.

Çetinözman F, Koens L, Jansen PM, Willemze R.

J Cutan Pathol. 2014 Jan;41(1):14-21. doi: 10.1111/cup.12254. Epub 2013 Nov 23.

PMID:
24151955
8.

Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma.

Tzankov A, Meier C, Hirschmann P, Went P, Pileri SA, Dirnhofer S.

Haematologica. 2008 Feb;93(2):193-200. doi: 10.3324/haematol.11702. Epub 2008 Jan 26.

9.

Expression of programmed death-1 (CD279) in primary cutaneous B-cell lymphomas with correlation to lymphoma entities and biological behaviour.

Mitteldorf C, Bieri M, Wey N, Kerl K, Kamarachev J, Pfaltz M, Kutzner H, Roncador G, Tomasini D, Kempf W.

Br J Dermatol. 2013 Dec;169(6):1212-8. doi: 10.1111/bjd.12579.

PMID:
23937075
11.

Angiogenesis in nodal B cell lymphomas: a high throughput study.

Tzankov A, Heiss S, Ebner S, Sterlacci W, Schaefer G, Augustin F, Fiegl M, Dirnhofer S.

J Clin Pathol. 2007 May;60(5):476-82. Epub 2006 Jun 21.

12.

Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma.

Roncador G, García Verdes-Montenegro JF, Tedoldi S, Paterson JC, Klapper W, Ballabio E, Maestre L, Pileri S, Hansmann ML, Piris MA, Mason DY, Marafioti T.

Haematologica. 2007 Aug;92(8):1059-66. Epub 2007 Jul 20.

13.

LEF1: a highly specific marker for the diagnosis of chronic lymphocytic B cell leukaemia/small lymphocytic B cell lymphoma.

Menter T, Dirnhofer S, Tzankov A.

J Clin Pathol. 2015 Jun;68(6):473-8. doi: 10.1136/jclinpath-2015-202862. Epub 2015 Feb 24.

PMID:
25713417
14.

PD-1 expression in T-cell lymphomas and reactive lymphoid entities: potential overlap in staining patterns between lymphoma and viral lymphadenitis.

Krishnan C, Warnke RA, Arber DA, Natkunam Y.

Am J Surg Pathol. 2010 Feb;34(2):178-89. doi: 10.1097/PAS.0b013e3181cc7e79. Erratum in: Am J Surg Pathol. 2010 May;34(5):688.

15.

Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas.

Krenacs L, Himmelmann AW, Quintanilla-Martinez L, Fest T, Riva A, Wellmann A, Bagdi E, Kehrl JH, Jaffe ES, Raffeld M.

Blood. 1998 Aug 15;92(4):1308-16.

16.
17.

Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia/small lymphocytic lymphoma in small B-cell lymphomas.

Tandon B, Peterson L, Gao J, Nelson B, Ma S, Rosen S, Chen YH.

Mod Pathol. 2011 Nov;24(11):1433-43. doi: 10.1038/modpathol.2011.103. Epub 2011 Jun 17.

18.

FcgammaRIIB is differentially expressed during B cell maturation and in B-cell lymphomas.

Camilleri-Broët S, Cassard L, Broët P, Delmer A, Le Touneau A, Diebold J, Fridman WH, Molina TJ, Sautès-Fridman C.

Br J Haematol. 2004 Jan;124(1):55-62.

PMID:
14675408
19.

Tumor-infiltrating T cells in primary cutaneous B-cell lympho-proliferative disorders.

Kamarashev J, Schaerer L, Burg G, Schmid MH, Müller B, Kempf W.

J Cutan Pathol. 2001 Oct;28(9):448-52.

PMID:
11553310
20.

Immunohistochemical detection of ZAP-70 in 341 cases of non-Hodgkin and Hodgkin lymphoma.

Admirand JH, Rassidakis GZ, Abruzzo LV, Valbuena JR, Jones D, Medeiros LJ.

Mod Pathol. 2004 Aug;17(8):954-61.

Items per page

Supplemental Content

Write to the Help Desk